National Priority Voucher Program
The FDA has announced the first nine companies to be part of its National Priority Voucher program.
This program aims to promote novel treatments that will benefit the health interests of Americans, including medications that meet a large, unmet need or reduce downstream health care utilization.
Medications that utilize MFN pricing can also be considered for the program.
A total of nine medications are on the initial list of program participants.
First announced in June of this year, the Priority Voucher program is a new initiative at the agency to promote novel treatments.
Author's summary: FDA announces participants in National Priority Voucher program.
More News
- Sportsnet | The incredible story of Jonathan Toews return to the NHL – Illegal Curve Hockey
- 'No Kings' protests against Trump planned nationwide, in what the GOP calls 'hate America' rallies
- “We know…” - Matthijs de Ligt makes bold “belief” claim ahead of Liverpool vs Man Utd
- TBA, Appraisal, Reverse Mortgage Tools; STRATMOR on AI and Competition; Can the CFPB be Willed Away?
- “Man Utd are quite convinced…” - Fabrizio Romano reveals “complete” star will leave Old Trafford in 2026
- Opinion: A place government doesn’t need to stick its nose | Juneau Empire
- Bombers win ugly to keep playoff hopes alive
- Matthijs de Ligt names Man Utd duo who sparked his childhood love for the club
- Marines Corps live-fire event at Camp Pendleton to close down large stretch of coastal freeway
- F1 | Red Bull, Verstappen: "The most important thing is winning the Sprint Race."